Evidence mapPaperPMID 39766328Full record

ArticleBiomolecules2024

COVID-19 Exacerbates Neurovascular Uncoupling and Contributes to Endothelial Dysfunction in Patients with Mild Cognitive Impairment.

Cameron D Owens, Camila B Pinto, Zsofia Szarvas, Mihaly Muranyi, Ana Clara da C Pinaffi-Langley, Anna Peterfi, Peter Mukli, Sam Detwiler, Lauren Olay, Zalan Kaposzta and 8 more

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Cameron D OwensOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.ORCID 0000-0002-5020-2810
Camila B PintoOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Zsofia SzarvasOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.ORCID 0000-0002-0022-5053
Mihaly MuranyiOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Ana Clara da C Pinaffi-LangleyOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.ORCID 0000-0001-6354-6658
Anna PeterfiOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Peter MukliOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.ORCID 0000-0003-4355-8103
Sam DetwilerOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Lauren OlayOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Zalan KaposztaOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Kenneth SmithOklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Angelia C KirkpatrickVeterans Affairs Medical Center, Oklahoma City, OK 73104, USA.
Faddi Saleh VelezDepartment of Neurology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA.ORCID 0000-0002-2626-6259
Stefano TarantiniOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.ORCID 0000-0001-5627-1430
Anna CsiszarOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Zoltan I UngvariOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Calin I ProdanVeterans Affairs Medical Center, Oklahoma City, OK 73104, USA.
Andriy YabluchanskiyOklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.ORCID 0000-0002-9648-7161

Funding

Tracking and Evaluation CoreU54GM104938 · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2025 to 2025
$4.4M
Chemotherapy-induced vascular cognitive impairment: role of endothelial senescenceR01CA255840 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2022 to 2025
$982k
Effects of NAD restoration on neurovascular coupling in community dwelling older adultsR01AG075834 · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2025 to 2025
$643k
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMAT32AG052363 · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2025 to 2025
$373k
Time-restricted feeding (TRF) for prevention of age-related vascular cognitive impairment and dementiaR03AG070479 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Stefano Tarantini · 2022 to 2022
$290k
Midlife Obesity, Neurovascular Senescence and Cognitive DeclineK01AG073614 · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2025 to 2025
$120k
American Heart Association 966924, 24CDA1276855, and 24DIVSUP1282484CSRD VA I01 CX000340CSRD VA I01 CX002578National Institutes of Health; the Oklahoma Shared Clinical and Translational Resources program U54GM104938NCI NIH HHS R01 CA255840NCI NIH HHS R01CA255840)NIA-funded Geroscience Training Program in Oklahoma T32AG052363NIA NIH HHS K01 AG073614NIA NIH HHS R01 AG068295NIA NIH HHS R01 AG075834NIA NIH HHS R03 AG070479NIA NIH HHS R21 AG080775NIA NIH HHS RF1 AG072295NIA NIH HHS RF1AG072295, R01AG068295, K01AG073614, and R03AG070479NIA NIH HHS T32 AG052363NIGMS NIH HHS U54 GM104938NIH HHS R01AG075834NIH HHS R21AG080775U.S. Department of Veterans Affairs Merit award numbers CX002578 and CX000340
6 · The paper itself

Abstract

Mild cognitive impairment (MCI) affects nearly 20% of older adults worldwide, with no targetable interventions for prevention. COVID-19 adversely affects cognition, with >70% of older adults with Long COVID presenting with cognitive complaints. Neurovascular coupling (NVC), an essential mechanism of cognitive function, declines with aging and is further attenuated in neurocognitive disorders. The effect of COVID-19 on NVC responses has yet to be addressed in older adults who are vulnerable to dementia progression. Participants with MCI and a history of COVID-19 (COV+, N = 31) and MCI participants with no history of infection (COV- N = 11) participated in this cross-sectional study to determine if COVID-19 affects cerebrocortical NVC responses and vascular function. Functional near-infrared spectroscopy was used to measure cerebrocortical NVC responses, and endothelial function was assessed via insonation of the brachial artery during a flow-mediated dilation protocol. NVC responses were elicited by the working memory

Indexed as

Cognitive DysfunctionCOVID-19Neurovascular CouplingAgedCross-Sectional StudiesEndothelium, VascularFemaleHumansMaleMiddle AgedSARS-CoV-2Spectroscopy, Near-InfraredCOVID-19endothelial functionflow-mediated dilationmild cognitive impairmentneurovascular coupling

Identifiers

PMID39766328
PMCPMC11726736

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.